TrianglePUBLICATIONS · 26786921
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2016 Mar 1
- First author
- Pollard JA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pollard JA
- type
- Author
- name
- Loken M
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Bernstein ID
- type
- Author
- name
- Gamis AS
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Meshinchi S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pollard JA
- type
- Author
- name
- Loken M
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Bernstein ID
- type
- Author
- name
- Gamis AS
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Meshinchi S
- type
- Author
- bibliography ids
- nci-bib-f3f6569d62a1fb796f5c2ca9
- book metadata
- content sha256
- 153776a52d2cc561d70ec3a8d4b4528c3b7ee21f5f421d159e15754abe58a1ae
- document type
- citation
- dois
- 10.1200/JCO.2015.62.6846
- electronic publication date
- display
- 2016 Jan 19
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26786921
- immutable id
- pubmed:26786921@153776a52d2cc561d70ec3a8d4b4528c3b7ee21f5f421d159e15754abe58a1ae
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 7
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 747-55
- volume
- 34
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26786921
- provenance
- batch id
- 948d34b0dea86780a31d
- provider
- NCBI PubMed ESummary
- record sha256
- e3c9cc3a0bca26768e35c38c3d35e55f9833c167d76a2d166b8bea62dab539e8
- response sha256
- 11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
- retrieved at
- 2026-09-09T23:47:15.495091+00:00
- publication date
- display
- 2016 Mar 1
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
Preserved source evidence · Not medical advice